E-LIB Suche - Ergebnisse für: Agema, Bram C.

1

Early Identification of Patients at Risk of Cabazitaxel-ind..:

Agema, Bram C. ; Buck, Stefan A.J. ; Viskil, Mano...
European Urology Oncology. , 2023

2

Toward model-informed precision dosing for tamoxifen: A pop..:

Agema, Bram C. ; Buijs, Sanne M. ; Sassen, Sebastiaan D.T....
Biomedicine & Pharmacotherapy. 160 (2023) - p. 114369 , 2023

Link: https://doi.org/10.1016/..

3

Improving the tolerability of osimertinib by identifying it..:

Agema, Bram C. ; Veerman, G. D. Marijn ; Steendam, Christi M. J....
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211032 , 2022

Link: https://doi.org/10.1177/..

4

Population Pharmacokinetics of Oxycodone and Metabolites in..:

Agema, Bram C. ; Oosten, Astrid W. ; Sassen, Sebastiaan D.T....
Cancers. 13 (2021) 11 - p. 2768 , 2021

Link: https://doi.org/10.3390/..

5

Influence of Genetic Variation in COMT on Cisplatin-Induced..:

Agema, Bram C. ; Koolen, Stijn L.W. ; de With, Mirjam...
Genes. 11 (2020) 4 - p. 358 , 2020

Link: https://doi.org/10.3390/..

6

The influence of single-nucleotide polymorphisms on overall..:

Belderbos, Bodine P. S. ; de With, Mirjam ; Singh, Rajbir K....
Cancer Chemotherapy and Pharmacology. 85 (2020) 3 - p. 547-553 , 2020

Link: https://doi.org/10.1007/..

7

Improving the tolerability of osimertinib by identifying it..:

Agema, Bram C ; Veerman, G. D. Marijn ; Steendam, Christi M. J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168866/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Population pharmacokinetics of oxycodone and metabolites in..:

Agema, Bram C ; Oosten, Astrid W ; Sassen, Sebastiaan D.T...
Agema , B C , Oosten , A W , Sassen , S D T , Rietdijk , W J R , van der Rijt , C C D , Koch , B C P , Mathijssen , R H J & Koolen , S L W 2021 , ' Population pharmacokinetics of oxycodone and metabolites in patients with cancer‐related pain ' , Cancers , vol. 13 , no. 11 , 2768 . https://doi.org/10.3390/cancers13112768. , 2021

Link: https://pure.eur.nl/en/p..

9

Population Pharmacokinetics of Oxycodone and Metabolites in..:

Agema, Bram C ; Oosten, Astrid W ; Sassen, Sebastiaan D.T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199682/. , 2021

Link: http://www.ncbi.nlm.nih...

10

The influence of single-nucleotide polymorphisms on overall..:

Belderbos, B.P.S.I. (Bodine) ; de With, M. (Mirjam) ; Singh, R.K. (Rajbir K.)...
http://repub.eur.nl/pub/123131. , 2020

Link: http://repub.eur.nl/pub/..

11

Influence of genetic variation in COMT on cisplatin-induced..:

Agema, B.C. (Bram C.) ; Koolen, S.L.W. (Stijn) ; de With, M. (Mirjam)...
http://repub.eur.nl/pub/126078. , 2020

Link: http://repub.eur.nl/pub/..

12

Toward model-informed precision dosing for tamoxifen: A pop..:

Bram C. Agema ; Sanne M. Buijs ; Sebastiaan D.T. Sassen...
http://www.sciencedirect.com/science/article/pii/S0753332223001579. , 2023

Link: https://doi.org/10.1016/..

13

Improving the tolerability of osimertinib by identifying it..:

Bram C. Agema ; G. D. Marijn Veerman ; Christi M. J. Steendam...
https://doi.org/10.1177/17588359221103212. , 2022

Link: https://doi.org/10.1177/..

14

Population Pharmacokinetics of Oxycodone and Metabolites in..:

Bram C. Agema ; Astrid W. Oosten ; Sebastiaan D.T. Sassen...
https://www.mdpi.com/2072-6694/13/11/2768. , 2021

Link: https://doi.org/10.3390/..

15

Population Pharmacokinetics of Oxycodone and Metabolites in..:

Bram C. Agema ; Astrid W. Oosten ; Sebastiaan D.T. Sassen...
Cancer Therapy. , 2021

Link: https://doi.org/10.3390/..